Cargando…

The prevalence of freezing of gait in Parkinson’s disease and in patients with different disease durations and severities

BACKGROUND: The prevalence rates of freezing of gait (FOG) in Parkinson’s disease (PD) vary widely, ranging from 14.0 to 55.1%. Our aim is to calculate the overall prevalence of FOG in all PD patients with different disease durations and severities. METHODS: Using Medline/PubMed/Embase, we carried o...

Descripción completa

Detalles Bibliográficos
Autores principales: Ge, Hong-Liang, Chen, Xiao-Yong, Lin, Yuan-Xiang, Ge, Ting-Juan, Yu, Liang-Hong, Lin, Zhang-Ya, Wu, Xi-Yue, Kang, De-Zhi, Ding, Chen-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398304/
https://www.ncbi.nlm.nih.gov/pubmed/32922946
http://dx.doi.org/10.1186/s41016-020-00197-y
_version_ 1783565937129029632
author Ge, Hong-Liang
Chen, Xiao-Yong
Lin, Yuan-Xiang
Ge, Ting-Juan
Yu, Liang-Hong
Lin, Zhang-Ya
Wu, Xi-Yue
Kang, De-Zhi
Ding, Chen-Yu
author_facet Ge, Hong-Liang
Chen, Xiao-Yong
Lin, Yuan-Xiang
Ge, Ting-Juan
Yu, Liang-Hong
Lin, Zhang-Ya
Wu, Xi-Yue
Kang, De-Zhi
Ding, Chen-Yu
author_sort Ge, Hong-Liang
collection PubMed
description BACKGROUND: The prevalence rates of freezing of gait (FOG) in Parkinson’s disease (PD) vary widely, ranging from 14.0 to 55.1%. Our aim is to calculate the overall prevalence of FOG in all PD patients with different disease durations and severities. METHODS: Using Medline/PubMed/Embase, we carried out a systematic literature search for studies reporting the PD and clinically relevant FOG. RESULTS: After primary screening, a total of 35 studies were identified and further analyzed for inclusion into the analysis, and 29 studies fulfilled the quality criteria and included in this meta-analysis. The overall prevalence of FOG in PD was 39.9% (95% CI 35.3-44.5%). The FOG identified by the freezing of gait questionnaire item 3 may be more prevalent (43.8%, 95% CI 38.5-49.1%) than the FOG identified by the Unified Parkinson’s Disease Rating Scale item 14 (36.0%, 95% CI 29.0-43.1%). Disease duration and severity are both the clinical features associated with the FOG. The highest FOG prevalence rate in PD patients was seen in patients with disease durations ≥ 10 years, at 70.8%, followed that of PD patients with disease durations ≥ 5 years (53.3%), and PD patients with disease durations < 5 years (22.4%). FOG presented in 28.4% of PD patients with Hoehn and Yahr staging (H&Y) score ≤ 2.5, and in 68.4% of PD patients with H&Y score ≥ 2.5. CONCLUSION: This meta-analysis confirms that the prevalence of FOG in PD is considerable, and highlights the need for accurate identification of FOG in PD.
format Online
Article
Text
id pubmed-7398304
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-73983042020-09-10 The prevalence of freezing of gait in Parkinson’s disease and in patients with different disease durations and severities Ge, Hong-Liang Chen, Xiao-Yong Lin, Yuan-Xiang Ge, Ting-Juan Yu, Liang-Hong Lin, Zhang-Ya Wu, Xi-Yue Kang, De-Zhi Ding, Chen-Yu Chin Neurosurg J Research BACKGROUND: The prevalence rates of freezing of gait (FOG) in Parkinson’s disease (PD) vary widely, ranging from 14.0 to 55.1%. Our aim is to calculate the overall prevalence of FOG in all PD patients with different disease durations and severities. METHODS: Using Medline/PubMed/Embase, we carried out a systematic literature search for studies reporting the PD and clinically relevant FOG. RESULTS: After primary screening, a total of 35 studies were identified and further analyzed for inclusion into the analysis, and 29 studies fulfilled the quality criteria and included in this meta-analysis. The overall prevalence of FOG in PD was 39.9% (95% CI 35.3-44.5%). The FOG identified by the freezing of gait questionnaire item 3 may be more prevalent (43.8%, 95% CI 38.5-49.1%) than the FOG identified by the Unified Parkinson’s Disease Rating Scale item 14 (36.0%, 95% CI 29.0-43.1%). Disease duration and severity are both the clinical features associated with the FOG. The highest FOG prevalence rate in PD patients was seen in patients with disease durations ≥ 10 years, at 70.8%, followed that of PD patients with disease durations ≥ 5 years (53.3%), and PD patients with disease durations < 5 years (22.4%). FOG presented in 28.4% of PD patients with Hoehn and Yahr staging (H&Y) score ≤ 2.5, and in 68.4% of PD patients with H&Y score ≥ 2.5. CONCLUSION: This meta-analysis confirms that the prevalence of FOG in PD is considerable, and highlights the need for accurate identification of FOG in PD. BioMed Central 2020-05-14 /pmc/articles/PMC7398304/ /pubmed/32922946 http://dx.doi.org/10.1186/s41016-020-00197-y Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Ge, Hong-Liang
Chen, Xiao-Yong
Lin, Yuan-Xiang
Ge, Ting-Juan
Yu, Liang-Hong
Lin, Zhang-Ya
Wu, Xi-Yue
Kang, De-Zhi
Ding, Chen-Yu
The prevalence of freezing of gait in Parkinson’s disease and in patients with different disease durations and severities
title The prevalence of freezing of gait in Parkinson’s disease and in patients with different disease durations and severities
title_full The prevalence of freezing of gait in Parkinson’s disease and in patients with different disease durations and severities
title_fullStr The prevalence of freezing of gait in Parkinson’s disease and in patients with different disease durations and severities
title_full_unstemmed The prevalence of freezing of gait in Parkinson’s disease and in patients with different disease durations and severities
title_short The prevalence of freezing of gait in Parkinson’s disease and in patients with different disease durations and severities
title_sort prevalence of freezing of gait in parkinson’s disease and in patients with different disease durations and severities
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398304/
https://www.ncbi.nlm.nih.gov/pubmed/32922946
http://dx.doi.org/10.1186/s41016-020-00197-y
work_keys_str_mv AT gehongliang theprevalenceoffreezingofgaitinparkinsonsdiseaseandinpatientswithdifferentdiseasedurationsandseverities
AT chenxiaoyong theprevalenceoffreezingofgaitinparkinsonsdiseaseandinpatientswithdifferentdiseasedurationsandseverities
AT linyuanxiang theprevalenceoffreezingofgaitinparkinsonsdiseaseandinpatientswithdifferentdiseasedurationsandseverities
AT getingjuan theprevalenceoffreezingofgaitinparkinsonsdiseaseandinpatientswithdifferentdiseasedurationsandseverities
AT yulianghong theprevalenceoffreezingofgaitinparkinsonsdiseaseandinpatientswithdifferentdiseasedurationsandseverities
AT linzhangya theprevalenceoffreezingofgaitinparkinsonsdiseaseandinpatientswithdifferentdiseasedurationsandseverities
AT wuxiyue theprevalenceoffreezingofgaitinparkinsonsdiseaseandinpatientswithdifferentdiseasedurationsandseverities
AT kangdezhi theprevalenceoffreezingofgaitinparkinsonsdiseaseandinpatientswithdifferentdiseasedurationsandseverities
AT dingchenyu theprevalenceoffreezingofgaitinparkinsonsdiseaseandinpatientswithdifferentdiseasedurationsandseverities
AT gehongliang prevalenceoffreezingofgaitinparkinsonsdiseaseandinpatientswithdifferentdiseasedurationsandseverities
AT chenxiaoyong prevalenceoffreezingofgaitinparkinsonsdiseaseandinpatientswithdifferentdiseasedurationsandseverities
AT linyuanxiang prevalenceoffreezingofgaitinparkinsonsdiseaseandinpatientswithdifferentdiseasedurationsandseverities
AT getingjuan prevalenceoffreezingofgaitinparkinsonsdiseaseandinpatientswithdifferentdiseasedurationsandseverities
AT yulianghong prevalenceoffreezingofgaitinparkinsonsdiseaseandinpatientswithdifferentdiseasedurationsandseverities
AT linzhangya prevalenceoffreezingofgaitinparkinsonsdiseaseandinpatientswithdifferentdiseasedurationsandseverities
AT wuxiyue prevalenceoffreezingofgaitinparkinsonsdiseaseandinpatientswithdifferentdiseasedurationsandseverities
AT kangdezhi prevalenceoffreezingofgaitinparkinsonsdiseaseandinpatientswithdifferentdiseasedurationsandseverities
AT dingchenyu prevalenceoffreezingofgaitinparkinsonsdiseaseandinpatientswithdifferentdiseasedurationsandseverities